nodes	percent_of_prediction	percent_of_DWPC	metapath
Auranofin—psoriatic arthritis—rheumatoid arthritis	0.492	1	CtDrD
Auranofin—IKBKB—Sulfasalazine—rheumatoid arthritis	0.213	0.902	CbGbCtD
Auranofin—ALB—rheumatoid arthritis	0.121	1	CbGaD
Auranofin—ALB—Prednisone—rheumatoid arthritis	0.0154	0.0652	CbGbCtD
Auranofin—ALB—Methotrexate—rheumatoid arthritis	0.00774	0.0327	CbGbCtD
Auranofin—PRDX5—exocrine gland—rheumatoid arthritis	0.00348	0.232	CbGeAlD
Auranofin—PRDX5—parotid gland—rheumatoid arthritis	0.00181	0.121	CbGeAlD
Auranofin—PRDX5—saliva-secreting gland—rheumatoid arthritis	0.00174	0.116	CbGeAlD
Auranofin—PRDX5—connective tissue—rheumatoid arthritis	0.0016	0.106	CbGeAlD
Auranofin—PRDX5—lymphoid tissue—rheumatoid arthritis	0.00117	0.0777	CbGeAlD
Auranofin—PRDX5—digestive system—rheumatoid arthritis	0.00115	0.0768	CbGeAlD
Auranofin—PRDX5—tendon—rheumatoid arthritis	0.0011	0.0731	CbGeAlD
Auranofin—IKBKB—connective tissue—rheumatoid arthritis	0.000945	0.063	CbGeAlD
Auranofin—IKBKB—lymphoid tissue—rheumatoid arthritis	0.000691	0.046	CbGeAlD
Auranofin—IKBKB—digestive system—rheumatoid arthritis	0.000683	0.0455	CbGeAlD
Auranofin—IKBKB—tendon—rheumatoid arthritis	0.00065	0.0433	CbGeAlD
Auranofin—Interstitial lung disease—Leflunomide—rheumatoid arthritis	0.000506	0.00879	CcSEcCtD
Auranofin—Gingivitis—Leflunomide—rheumatoid arthritis	0.000457	0.00792	CcSEcCtD
Auranofin—Eosinophilia—Penicillamine—rheumatoid arthritis	0.000453	0.00786	CcSEcCtD
Auranofin—Pancytopenia—Penicillamine—rheumatoid arthritis	0.000434	0.00754	CcSEcCtD
Auranofin—Neuropathy peripheral—Penicillamine—rheumatoid arthritis	0.0004	0.00694	CcSEcCtD
Auranofin—Stomatitis—Penicillamine—rheumatoid arthritis	0.000398	0.0069	CcSEcCtD
Auranofin—Anaemia—Ergocalciferol—rheumatoid arthritis	0.000391	0.00679	CcSEcCtD
Auranofin—Interstitial lung disease—Cyclosporine—rheumatoid arthritis	0.000391	0.00678	CcSEcCtD
Auranofin—Haematuria—Penicillamine—rheumatoid arthritis	0.000389	0.00675	CcSEcCtD
Auranofin—Agranulocytosis—Penicillamine—rheumatoid arthritis	0.000381	0.0066	CcSEcCtD
Auranofin—Hepatic enzyme increased—Leflunomide—rheumatoid arthritis	0.000379	0.00657	CcSEcCtD
Auranofin—Aplastic anaemia—Azathioprine—rheumatoid arthritis	0.000356	0.00618	CcSEcCtD
Auranofin—Gingivitis—Cyclosporine—rheumatoid arthritis	0.000352	0.00611	CcSEcCtD
Auranofin—Melaena—Leflunomide—rheumatoid arthritis	0.00035	0.00607	CcSEcCtD
Auranofin—Anorexia—Ergocalciferol—rheumatoid arthritis	0.000329	0.00571	CcSEcCtD
Auranofin—Alopecia—Penicillamine—rheumatoid arthritis	0.000324	0.00561	CcSEcCtD
Auranofin—Interstitial pneumonia—Methotrexate—rheumatoid arthritis	0.000316	0.00549	CcSEcCtD
Auranofin—Dysgeusia—Penicillamine—rheumatoid arthritis	0.000312	0.00542	CcSEcCtD
Auranofin—Decreased appetite—Ergocalciferol—rheumatoid arthritis	0.0003	0.00521	CcSEcCtD
Auranofin—Glossitis—Cyclosporine—rheumatoid arthritis	0.0003	0.00521	CcSEcCtD
Auranofin—Constipation—Ergocalciferol—rheumatoid arthritis	0.000296	0.00513	CcSEcCtD
Auranofin—Anaemia—Penicillamine—rheumatoid arthritis	0.000295	0.00511	CcSEcCtD
Auranofin—Leukopenia—Penicillamine—rheumatoid arthritis	0.000285	0.00495	CcSEcCtD
Auranofin—Thrombocytopenia—Penicillamine—rheumatoid arthritis	0.000255	0.00442	CcSEcCtD
Auranofin—Anorexia—Penicillamine—rheumatoid arthritis	0.000248	0.0043	CcSEcCtD
Auranofin—Pancytopenia—Azathioprine—rheumatoid arthritis	0.000226	0.00392	CcSEcCtD
Auranofin—Decreased appetite—Penicillamine—rheumatoid arthritis	0.000226	0.00392	CcSEcCtD
Auranofin—Eosinophilia—Leflunomide—rheumatoid arthritis	0.000223	0.00386	CcSEcCtD
Auranofin—Interstitial lung disease—Methotrexate—rheumatoid arthritis	0.000216	0.00375	CcSEcCtD
Auranofin—Pancytopenia—Leflunomide—rheumatoid arthritis	0.000214	0.00371	CcSEcCtD
Auranofin—Neutropenia—Leflunomide—rheumatoid arthritis	0.00021	0.00365	CcSEcCtD
Auranofin—Urticaria—Penicillamine—rheumatoid arthritis	0.000207	0.00359	CcSEcCtD
Auranofin—Nausea—Ergocalciferol—rheumatoid arthritis	0.000205	0.00356	CcSEcCtD
Auranofin—Weight decreased—Leflunomide—rheumatoid arthritis	0.000203	0.00353	CcSEcCtD
Auranofin—Agranulocytosis—Azathioprine—rheumatoid arthritis	0.000198	0.00344	CcSEcCtD
Auranofin—Neuropathy peripheral—Leflunomide—rheumatoid arthritis	0.000197	0.00341	CcSEcCtD
Auranofin—Stomatitis—Leflunomide—rheumatoid arthritis	0.000195	0.00339	CcSEcCtD
Auranofin—Jaundice—Leflunomide—rheumatoid arthritis	0.000195	0.00339	CcSEcCtD
Auranofin—Conjunctivitis—Leflunomide—rheumatoid arthritis	0.000195	0.00338	CcSEcCtD
Auranofin—Gingivitis—Methotrexate—rheumatoid arthritis	0.000195	0.00338	CcSEcCtD
Auranofin—Haematuria—Leflunomide—rheumatoid arthritis	0.000191	0.00332	CcSEcCtD
Auranofin—Agranulocytosis—Leflunomide—rheumatoid arthritis	0.000187	0.00325	CcSEcCtD
Auranofin—Diarrhoea—Penicillamine—rheumatoid arthritis	0.000178	0.00309	CcSEcCtD
Auranofin—Proteinuria—Methotrexate—rheumatoid arthritis	0.000174	0.00302	CcSEcCtD
Auranofin—Dysphagia—Cyclosporine—rheumatoid arthritis	0.000174	0.00301	CcSEcCtD
Auranofin—Protein urine present—Methotrexate—rheumatoid arthritis	0.000172	0.00298	CcSEcCtD
Auranofin—Alopecia—Azathioprine—rheumatoid arthritis	0.000168	0.00292	CcSEcCtD
Auranofin—Eye disorder—Leflunomide—rheumatoid arthritis	0.000168	0.00292	CcSEcCtD
Auranofin—Glossitis—Methotrexate—rheumatoid arthritis	0.000166	0.00288	CcSEcCtD
Auranofin—Vomiting—Penicillamine—rheumatoid arthritis	0.000165	0.00287	CcSEcCtD
Auranofin—Rash—Penicillamine—rheumatoid arthritis	0.000164	0.00285	CcSEcCtD
Auranofin—Dermatitis—Penicillamine—rheumatoid arthritis	0.000164	0.00284	CcSEcCtD
Auranofin—Hepatic enzyme increased—Methotrexate—rheumatoid arthritis	0.000162	0.0028	CcSEcCtD
Auranofin—Alopecia—Leflunomide—rheumatoid arthritis	0.000159	0.00276	CcSEcCtD
Auranofin—Weight decreased—Cyclosporine—rheumatoid arthritis	0.000157	0.00272	CcSEcCtD
Auranofin—Nausea—Penicillamine—rheumatoid arthritis	0.000155	0.00268	CcSEcCtD
Auranofin—Flatulence—Leflunomide—rheumatoid arthritis	0.000154	0.00268	CcSEcCtD
Auranofin—Dysgeusia—Leflunomide—rheumatoid arthritis	0.000153	0.00266	CcSEcCtD
Auranofin—Anaemia—Azathioprine—rheumatoid arthritis	0.000153	0.00266	CcSEcCtD
Auranofin—Neuropathy peripheral—Cyclosporine—rheumatoid arthritis	0.000152	0.00263	CcSEcCtD
Auranofin—Jaundice—Cyclosporine—rheumatoid arthritis	0.000151	0.00262	CcSEcCtD
Auranofin—Stomatitis—Cyclosporine—rheumatoid arthritis	0.000151	0.00262	CcSEcCtD
Auranofin—Conjunctivitis—Cyclosporine—rheumatoid arthritis	0.00015	0.00261	CcSEcCtD
Auranofin—Melaena—Methotrexate—rheumatoid arthritis	0.000149	0.00259	CcSEcCtD
Auranofin—Leukopenia—Azathioprine—rheumatoid arthritis	0.000149	0.00258	CcSEcCtD
Auranofin—Haematuria—Cyclosporine—rheumatoid arthritis	0.000148	0.00256	CcSEcCtD
Auranofin—Anaemia—Leflunomide—rheumatoid arthritis	0.000145	0.00251	CcSEcCtD
Auranofin—Aplastic anaemia—Methotrexate—rheumatoid arthritis	0.000144	0.00249	CcSEcCtD
Auranofin—Angioedema—Leflunomide—rheumatoid arthritis	0.000143	0.00248	CcSEcCtD
Auranofin—Leukopenia—Leflunomide—rheumatoid arthritis	0.00014	0.00243	CcSEcCtD
Auranofin—Weight decreased—Hydrocortisone—rheumatoid arthritis	0.00014	0.00242	CcSEcCtD
Auranofin—Neuropathy peripheral—Prednisolone—rheumatoid arthritis	0.000138	0.00239	CcSEcCtD
Auranofin—Conjunctivitis—Prednisolone—rheumatoid arthritis	0.000137	0.00237	CcSEcCtD
Auranofin—Neuropathy peripheral—Hydrocortisone—rheumatoid arthritis	0.000135	0.00234	CcSEcCtD
Auranofin—Visual impairment—Cyclosporine—rheumatoid arthritis	0.000134	0.00232	CcSEcCtD
Auranofin—Gastrointestinal haemorrhage—Prednisone—rheumatoid arthritis	0.000133	0.0023	CcSEcCtD
Auranofin—Thrombocytopenia—Azathioprine—rheumatoid arthritis	0.000133	0.0023	CcSEcCtD
Auranofin—Neuropathy peripheral—Triamcinolone—rheumatoid arthritis	0.000127	0.0022	CcSEcCtD
Auranofin—Neuropathy peripheral—Methylprednisolone—rheumatoid arthritis	0.000127	0.0022	CcSEcCtD
Auranofin—Conjunctivitis—Triamcinolone—rheumatoid arthritis	0.000126	0.00218	CcSEcCtD
Auranofin—Thrombocytopenia—Leflunomide—rheumatoid arthritis	0.000125	0.00217	CcSEcCtD
Auranofin—Alopecia—Cyclosporine—rheumatoid arthritis	0.000123	0.00213	CcSEcCtD
Auranofin—Anorexia—Leflunomide—rheumatoid arthritis	0.000122	0.00211	CcSEcCtD
Auranofin—Visual impairment—Prednisolone—rheumatoid arthritis	0.000122	0.00211	CcSEcCtD
Auranofin—Weight decreased—Betamethasone—rheumatoid arthritis	0.000119	0.00207	CcSEcCtD
Auranofin—Weight decreased—Dexamethasone—rheumatoid arthritis	0.000119	0.00207	CcSEcCtD
Auranofin—Flatulence—Cyclosporine—rheumatoid arthritis	0.000119	0.00207	CcSEcCtD
Auranofin—Dysgeusia—Cyclosporine—rheumatoid arthritis	0.000118	0.00205	CcSEcCtD
Auranofin—Dermatitis exfoliative—Methotrexate—rheumatoid arthritis	0.000118	0.00204	CcSEcCtD
Auranofin—Eye disorder—Hydrocortisone—rheumatoid arthritis	0.000115	0.002	CcSEcCtD
Auranofin—Neuropathy peripheral—Betamethasone—rheumatoid arthritis	0.000115	0.002	CcSEcCtD
Auranofin—Neuropathy peripheral—Dexamethasone—rheumatoid arthritis	0.000115	0.002	CcSEcCtD
Auranofin—Conjunctivitis—Betamethasone—rheumatoid arthritis	0.000114	0.00198	CcSEcCtD
Auranofin—Conjunctivitis—Dexamethasone—rheumatoid arthritis	0.000114	0.00198	CcSEcCtD
Auranofin—Dyspepsia—Leflunomide—rheumatoid arthritis	0.000113	0.00195	CcSEcCtD
Auranofin—Visual impairment—Methylprednisolone—rheumatoid arthritis	0.000112	0.00194	CcSEcCtD
Auranofin—Anaemia—Cyclosporine—rheumatoid arthritis	0.000112	0.00194	CcSEcCtD
Auranofin—Decreased appetite—Leflunomide—rheumatoid arthritis	0.000111	0.00193	CcSEcCtD
Auranofin—Gastrointestinal pain—Azathioprine—rheumatoid arthritis	0.000111	0.00192	CcSEcCtD
Auranofin—Angioedema—Cyclosporine—rheumatoid arthritis	0.000111	0.00192	CcSEcCtD
Auranofin—Constipation—Leflunomide—rheumatoid arthritis	0.000109	0.0019	CcSEcCtD
Auranofin—Eye disorder—Methylprednisolone—rheumatoid arthritis	0.000108	0.00188	CcSEcCtD
Auranofin—Leukopenia—Cyclosporine—rheumatoid arthritis	0.000108	0.00188	CcSEcCtD
Auranofin—Neutropenia—Prednisone—rheumatoid arthritis	0.000107	0.00186	CcSEcCtD
Auranofin—Abdominal pain—Azathioprine—rheumatoid arthritis	0.000107	0.00186	CcSEcCtD
Auranofin—Gastrointestinal pain—Leflunomide—rheumatoid arthritis	0.000105	0.00181	CcSEcCtD
Auranofin—Weight decreased—Prednisone—rheumatoid arthritis	0.000104	0.0018	CcSEcCtD
Auranofin—Visual impairment—Dexamethasone—rheumatoid arthritis	0.000102	0.00176	CcSEcCtD
Auranofin—Visual impairment—Betamethasone—rheumatoid arthritis	0.000102	0.00176	CcSEcCtD
Auranofin—Urticaria—Leflunomide—rheumatoid arthritis	0.000102	0.00176	CcSEcCtD
Auranofin—Abdominal pain—Leflunomide—rheumatoid arthritis	0.000101	0.00175	CcSEcCtD
Auranofin—Angioedema—Prednisolone—rheumatoid arthritis	0.000101	0.00174	CcSEcCtD
Auranofin—Neuropathy peripheral—Prednisone—rheumatoid arthritis	0.0001	0.00174	CcSEcCtD
Auranofin—Dysgeusia—Triamcinolone—rheumatoid arthritis	9.91e-05	0.00172	CcSEcCtD
Auranofin—Eye disorder—Dexamethasone—rheumatoid arthritis	9.86e-05	0.00171	CcSEcCtD
Auranofin—Eye disorder—Betamethasone—rheumatoid arthritis	9.86e-05	0.00171	CcSEcCtD
Auranofin—Angioedema—Hydrocortisone—rheumatoid arthritis	9.82e-05	0.0017	CcSEcCtD
Auranofin—Thrombocytopenia—Cyclosporine—rheumatoid arthritis	9.66e-05	0.00168	CcSEcCtD
Auranofin—Eosinophilia—Methotrexate—rheumatoid arthritis	9.5e-05	0.00165	CcSEcCtD
Auranofin—Anorexia—Cyclosporine—rheumatoid arthritis	9.41e-05	0.00163	CcSEcCtD
Auranofin—Alopecia—Betamethasone—rheumatoid arthritis	9.32e-05	0.00162	CcSEcCtD
Auranofin—Alopecia—Dexamethasone—rheumatoid arthritis	9.32e-05	0.00162	CcSEcCtD
Auranofin—Diarrhoea—Azathioprine—rheumatoid arthritis	9.27e-05	0.00161	CcSEcCtD
Auranofin—Angioedema—Triamcinolone—rheumatoid arthritis	9.25e-05	0.0016	CcSEcCtD
Auranofin—Angioedema—Methylprednisolone—rheumatoid arthritis	9.23e-05	0.0016	CcSEcCtD
Auranofin—Pancytopenia—Methotrexate—rheumatoid arthritis	9.11e-05	0.00158	CcSEcCtD
Auranofin—Pruritus—Leflunomide—rheumatoid arthritis	9.05e-05	0.00157	CcSEcCtD
Auranofin—Neutropenia—Methotrexate—rheumatoid arthritis	8.97e-05	0.00156	CcSEcCtD
Auranofin—Diarrhoea—Leflunomide—rheumatoid arthritis	8.75e-05	0.00152	CcSEcCtD
Auranofin—Dyspepsia—Cyclosporine—rheumatoid arthritis	8.69e-05	0.00151	CcSEcCtD
Auranofin—Vomiting—Azathioprine—rheumatoid arthritis	8.61e-05	0.00149	CcSEcCtD
Auranofin—Eye disorder—Prednisone—rheumatoid arthritis	8.59e-05	0.00149	CcSEcCtD
Auranofin—Decreased appetite—Cyclosporine—rheumatoid arthritis	8.58e-05	0.00149	CcSEcCtD
Auranofin—Rash—Azathioprine—rheumatoid arthritis	8.54e-05	0.00148	CcSEcCtD
Auranofin—Dermatitis—Azathioprine—rheumatoid arthritis	8.53e-05	0.00148	CcSEcCtD
Auranofin—Constipation—Cyclosporine—rheumatoid arthritis	8.44e-05	0.00146	CcSEcCtD
Auranofin—Angioedema—Dexamethasone—rheumatoid arthritis	8.39e-05	0.00146	CcSEcCtD
Auranofin—Angioedema—Betamethasone—rheumatoid arthritis	8.39e-05	0.00146	CcSEcCtD
Auranofin—Anorexia—Hydrocortisone—rheumatoid arthritis	8.36e-05	0.00145	CcSEcCtD
Auranofin—Stomatitis—Methotrexate—rheumatoid arthritis	8.34e-05	0.00145	CcSEcCtD
Auranofin—Conjunctivitis—Methotrexate—rheumatoid arthritis	8.31e-05	0.00144	CcSEcCtD
Auranofin—Haematuria—Methotrexate—rheumatoid arthritis	8.15e-05	0.00141	CcSEcCtD
Auranofin—Vomiting—Leflunomide—rheumatoid arthritis	8.13e-05	0.00141	CcSEcCtD
Auranofin—Alopecia—Prednisone—rheumatoid arthritis	8.12e-05	0.00141	CcSEcCtD
Auranofin—Gastrointestinal pain—Cyclosporine—rheumatoid arthritis	8.07e-05	0.0014	CcSEcCtD
Auranofin—Rash—Leflunomide—rheumatoid arthritis	8.06e-05	0.0014	CcSEcCtD
Auranofin—Dermatitis—Leflunomide—rheumatoid arthritis	8.06e-05	0.0014	CcSEcCtD
Auranofin—Nausea—Azathioprine—rheumatoid arthritis	8.04e-05	0.0014	CcSEcCtD
Auranofin—Agranulocytosis—Methotrexate—rheumatoid arthritis	7.98e-05	0.00138	CcSEcCtD
Auranofin—Urticaria—Cyclosporine—rheumatoid arthritis	7.84e-05	0.00136	CcSEcCtD
Auranofin—Abdominal pain—Cyclosporine—rheumatoid arthritis	7.8e-05	0.00135	CcSEcCtD
Auranofin—Dyspepsia—Hydrocortisone—rheumatoid arthritis	7.72e-05	0.00134	CcSEcCtD
Auranofin—Decreased appetite—Hydrocortisone—rheumatoid arthritis	7.63e-05	0.00132	CcSEcCtD
Auranofin—Nausea—Leflunomide—rheumatoid arthritis	7.6e-05	0.00132	CcSEcCtD
Auranofin—Visual impairment—Methotrexate—rheumatoid arthritis	7.4e-05	0.00128	CcSEcCtD
Auranofin—Anaemia—Prednisone—rheumatoid arthritis	7.39e-05	0.00128	CcSEcCtD
Auranofin—Thrombocytopenia—Dexamethasone—rheumatoid arthritis	7.34e-05	0.00127	CcSEcCtD
Auranofin—Thrombocytopenia—Betamethasone—rheumatoid arthritis	7.34e-05	0.00127	CcSEcCtD
Auranofin—Angioedema—Prednisone—rheumatoid arthritis	7.31e-05	0.00127	CcSEcCtD
Auranofin—Dyspepsia—Triamcinolone—rheumatoid arthritis	7.27e-05	0.00126	CcSEcCtD
Auranofin—Dyspepsia—Methylprednisolone—rheumatoid arthritis	7.25e-05	0.00126	CcSEcCtD
Auranofin—Eye disorder—Methotrexate—rheumatoid arthritis	7.17e-05	0.00124	CcSEcCtD
Auranofin—Gastrointestinal pain—Hydrocortisone—rheumatoid arthritis	7.17e-05	0.00124	CcSEcCtD
Auranofin—Anorexia—Dexamethasone—rheumatoid arthritis	7.14e-05	0.00124	CcSEcCtD
Auranofin—Anorexia—Betamethasone—rheumatoid arthritis	7.14e-05	0.00124	CcSEcCtD
Auranofin—Urticaria—Prednisolone—rheumatoid arthritis	7.14e-05	0.00124	CcSEcCtD
Auranofin—Pruritus—Cyclosporine—rheumatoid arthritis	6.98e-05	0.00121	CcSEcCtD
Auranofin—Urticaria—Hydrocortisone—rheumatoid arthritis	6.97e-05	0.00121	CcSEcCtD
Auranofin—Abdominal pain—Hydrocortisone—rheumatoid arthritis	6.93e-05	0.0012	CcSEcCtD
Auranofin—Alopecia—Methotrexate—rheumatoid arthritis	6.78e-05	0.00118	CcSEcCtD
Auranofin—Diarrhoea—Cyclosporine—rheumatoid arthritis	6.75e-05	0.00117	CcSEcCtD
Auranofin—Gastrointestinal pain—Methylprednisolone—rheumatoid arthritis	6.74e-05	0.00117	CcSEcCtD
Auranofin—Dyspepsia—Dexamethasone—rheumatoid arthritis	6.6e-05	0.00114	CcSEcCtD
Auranofin—Dyspepsia—Betamethasone—rheumatoid arthritis	6.6e-05	0.00114	CcSEcCtD
Auranofin—Urticaria—Triamcinolone—rheumatoid arthritis	6.56e-05	0.00114	CcSEcCtD
Auranofin—Urticaria—Methylprednisolone—rheumatoid arthritis	6.55e-05	0.00114	CcSEcCtD
Auranofin—Dysgeusia—Methotrexate—rheumatoid arthritis	6.54e-05	0.00114	CcSEcCtD
Auranofin—Abdominal pain—Methylprednisolone—rheumatoid arthritis	6.52e-05	0.00113	CcSEcCtD
Auranofin—Decreased appetite—Betamethasone—rheumatoid arthritis	6.52e-05	0.00113	CcSEcCtD
Auranofin—Decreased appetite—Dexamethasone—rheumatoid arthritis	6.52e-05	0.00113	CcSEcCtD
Auranofin—Vomiting—Cyclosporine—rheumatoid arthritis	6.28e-05	0.00109	CcSEcCtD
Auranofin—Rash—Cyclosporine—rheumatoid arthritis	6.22e-05	0.00108	CcSEcCtD
Auranofin—Anorexia—Prednisone—rheumatoid arthritis	6.22e-05	0.00108	CcSEcCtD
Auranofin—Dermatitis—Cyclosporine—rheumatoid arthritis	6.22e-05	0.00108	CcSEcCtD
Auranofin—Pruritus—Hydrocortisone—rheumatoid arthritis	6.21e-05	0.00108	CcSEcCtD
Auranofin—Anaemia—Methotrexate—rheumatoid arthritis	6.18e-05	0.00107	CcSEcCtD
Auranofin—Gastrointestinal pain—Betamethasone—rheumatoid arthritis	6.13e-05	0.00106	CcSEcCtD
Auranofin—Gastrointestinal pain—Dexamethasone—rheumatoid arthritis	6.13e-05	0.00106	CcSEcCtD
Auranofin—Diarrhoea—Hydrocortisone—rheumatoid arthritis	6e-05	0.00104	CcSEcCtD
Auranofin—Leukopenia—Methotrexate—rheumatoid arthritis	5.98e-05	0.00104	CcSEcCtD
Auranofin—Urticaria—Betamethasone—rheumatoid arthritis	5.95e-05	0.00103	CcSEcCtD
Auranofin—Urticaria—Dexamethasone—rheumatoid arthritis	5.95e-05	0.00103	CcSEcCtD
Auranofin—Abdominal pain—Betamethasone—rheumatoid arthritis	5.92e-05	0.00103	CcSEcCtD
Auranofin—Abdominal pain—Dexamethasone—rheumatoid arthritis	5.92e-05	0.00103	CcSEcCtD
Auranofin—Nausea—Cyclosporine—rheumatoid arthritis	5.86e-05	0.00102	CcSEcCtD
Auranofin—Pruritus—Triamcinolone—rheumatoid arthritis	5.84e-05	0.00101	CcSEcCtD
Auranofin—Pruritus—Methylprednisolone—rheumatoid arthritis	5.83e-05	0.00101	CcSEcCtD
Auranofin—Dyspepsia—Prednisone—rheumatoid arthritis	5.75e-05	0.000997	CcSEcCtD
Auranofin—Decreased appetite—Prednisone—rheumatoid arthritis	5.67e-05	0.000984	CcSEcCtD
Auranofin—Rash—Prednisolone—rheumatoid arthritis	5.66e-05	0.000982	CcSEcCtD
Auranofin—Dermatitis—Prednisolone—rheumatoid arthritis	5.66e-05	0.000981	CcSEcCtD
Auranofin—Diarrhoea—Methylprednisolone—rheumatoid arthritis	5.64e-05	0.000978	CcSEcCtD
Auranofin—Constipation—Prednisone—rheumatoid arthritis	5.58e-05	0.000968	CcSEcCtD
Auranofin—Vomiting—Hydrocortisone—rheumatoid arthritis	5.58e-05	0.000968	CcSEcCtD
Auranofin—Rash—Hydrocortisone—rheumatoid arthritis	5.53e-05	0.000959	CcSEcCtD
Auranofin—Dermatitis—Hydrocortisone—rheumatoid arthritis	5.53e-05	0.000959	CcSEcCtD
Auranofin—Thrombocytopenia—Methotrexate—rheumatoid arthritis	5.34e-05	0.000926	CcSEcCtD
Auranofin—Gastrointestinal pain—Prednisone—rheumatoid arthritis	5.34e-05	0.000926	CcSEcCtD
Auranofin—Nausea—Prednisolone—rheumatoid arthritis	5.34e-05	0.000925	CcSEcCtD
Auranofin—Pruritus—Dexamethasone—rheumatoid arthritis	5.3e-05	0.00092	CcSEcCtD
Auranofin—Pruritus—Betamethasone—rheumatoid arthritis	5.3e-05	0.00092	CcSEcCtD
Auranofin—Vomiting—Triamcinolone—rheumatoid arthritis	5.25e-05	0.000911	CcSEcCtD
Auranofin—Vomiting—Methylprednisolone—rheumatoid arthritis	5.24e-05	0.000909	CcSEcCtD
Auranofin—Nausea—Hydrocortisone—rheumatoid arthritis	5.21e-05	0.000904	CcSEcCtD
Auranofin—Rash—Triamcinolone—rheumatoid arthritis	5.21e-05	0.000903	CcSEcCtD
Auranofin—Dermatitis—Triamcinolone—rheumatoid arthritis	5.2e-05	0.000903	CcSEcCtD
Auranofin—Anorexia—Methotrexate—rheumatoid arthritis	5.2e-05	0.000902	CcSEcCtD
Auranofin—Rash—Methylprednisolone—rheumatoid arthritis	5.2e-05	0.000901	CcSEcCtD
Auranofin—Dermatitis—Methylprednisolone—rheumatoid arthritis	5.19e-05	0.000901	CcSEcCtD
Auranofin—Urticaria—Prednisone—rheumatoid arthritis	5.19e-05	0.000899	CcSEcCtD
Auranofin—Abdominal pain—Prednisone—rheumatoid arthritis	5.16e-05	0.000895	CcSEcCtD
Auranofin—Diarrhoea—Dexamethasone—rheumatoid arthritis	5.13e-05	0.00089	CcSEcCtD
Auranofin—Diarrhoea—Betamethasone—rheumatoid arthritis	5.13e-05	0.00089	CcSEcCtD
Auranofin—Nausea—Triamcinolone—rheumatoid arthritis	4.91e-05	0.000851	CcSEcCtD
Auranofin—Nausea—Methylprednisolone—rheumatoid arthritis	4.9e-05	0.000849	CcSEcCtD
Auranofin—Dyspepsia—Methotrexate—rheumatoid arthritis	4.8e-05	0.000833	CcSEcCtD
Auranofin—Vomiting—Dexamethasone—rheumatoid arthritis	4.77e-05	0.000827	CcSEcCtD
Auranofin—Vomiting—Betamethasone—rheumatoid arthritis	4.77e-05	0.000827	CcSEcCtD
Auranofin—Decreased appetite—Methotrexate—rheumatoid arthritis	4.74e-05	0.000823	CcSEcCtD
Auranofin—Rash—Dexamethasone—rheumatoid arthritis	4.73e-05	0.00082	CcSEcCtD
Auranofin—Rash—Betamethasone—rheumatoid arthritis	4.73e-05	0.00082	CcSEcCtD
Auranofin—Dermatitis—Dexamethasone—rheumatoid arthritis	4.72e-05	0.000819	CcSEcCtD
Auranofin—Dermatitis—Betamethasone—rheumatoid arthritis	4.72e-05	0.000819	CcSEcCtD
Auranofin—Pruritus—Prednisone—rheumatoid arthritis	4.62e-05	0.000801	CcSEcCtD
Auranofin—Diarrhoea—Prednisone—rheumatoid arthritis	4.47e-05	0.000775	CcSEcCtD
Auranofin—Gastrointestinal pain—Methotrexate—rheumatoid arthritis	4.46e-05	0.000774	CcSEcCtD
Auranofin—Nausea—Betamethasone—rheumatoid arthritis	4.45e-05	0.000772	CcSEcCtD
Auranofin—Nausea—Dexamethasone—rheumatoid arthritis	4.45e-05	0.000772	CcSEcCtD
Auranofin—Urticaria—Methotrexate—rheumatoid arthritis	4.33e-05	0.000752	CcSEcCtD
Auranofin—Abdominal pain—Methotrexate—rheumatoid arthritis	4.31e-05	0.000748	CcSEcCtD
Auranofin—Vomiting—Prednisone—rheumatoid arthritis	4.15e-05	0.00072	CcSEcCtD
Auranofin—Rash—Prednisone—rheumatoid arthritis	4.12e-05	0.000714	CcSEcCtD
Auranofin—Dermatitis—Prednisone—rheumatoid arthritis	4.11e-05	0.000713	CcSEcCtD
Auranofin—Nausea—Prednisone—rheumatoid arthritis	3.88e-05	0.000673	CcSEcCtD
Auranofin—Pruritus—Methotrexate—rheumatoid arthritis	3.86e-05	0.000669	CcSEcCtD
Auranofin—Diarrhoea—Methotrexate—rheumatoid arthritis	3.73e-05	0.000647	CcSEcCtD
Auranofin—Vomiting—Methotrexate—rheumatoid arthritis	3.47e-05	0.000602	CcSEcCtD
Auranofin—Rash—Methotrexate—rheumatoid arthritis	3.44e-05	0.000597	CcSEcCtD
Auranofin—Dermatitis—Methotrexate—rheumatoid arthritis	3.44e-05	0.000596	CcSEcCtD
Auranofin—Nausea—Methotrexate—rheumatoid arthritis	3.24e-05	0.000562	CcSEcCtD
Auranofin—IKBKB—Adaptive Immune System—HLA-DPB1—rheumatoid arthritis	1.73e-05	0.000225	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—UBE2D1—rheumatoid arthritis	1.72e-05	0.000223	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—MAPK8—rheumatoid arthritis	1.72e-05	0.000223	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—HMGB1—rheumatoid arthritis	1.71e-05	0.000222	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—TAGAP—rheumatoid arthritis	1.69e-05	0.000219	CbGpPWpGaD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—NFKB1—rheumatoid arthritis	1.67e-05	0.000217	CbGpPWpGaD
Auranofin—IKBKB—MyD88-independent cascade—IL6—rheumatoid arthritis	1.67e-05	0.000217	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—CD40—rheumatoid arthritis	1.67e-05	0.000216	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—MED1—rheumatoid arthritis	1.66e-05	0.000216	CbGpPWpGaD
Auranofin—ALB—Selenium Micronutrient Network—IL1B—rheumatoid arthritis	1.66e-05	0.000215	CbGpPWpGaD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—MAPK8—rheumatoid arthritis	1.65e-05	0.000213	CbGpPWpGaD
Auranofin—IKBKB—Immune System—FCGR3A—rheumatoid arthritis	1.64e-05	0.000213	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—CTLA4—rheumatoid arthritis	1.64e-05	0.000213	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—RASGRP1—rheumatoid arthritis	1.64e-05	0.000212	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—IL6R—rheumatoid arthritis	1.63e-05	0.000212	CbGpPWpGaD
Auranofin—IKBKB—Toll-like Receptor Signaling Pathway—IL6—rheumatoid arthritis	1.63e-05	0.000212	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—SYK—rheumatoid arthritis	1.63e-05	0.000211	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—IL6R—rheumatoid arthritis	1.61e-05	0.000208	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—PRKCQ—rheumatoid arthritis	1.6e-05	0.000208	CbGpPWpGaD
Auranofin—ALB—Transmembrane transport of small molecules—MED1—rheumatoid arthritis	1.58e-05	0.000205	CbGpPWpGaD
Auranofin—IKBKB—Regulation of toll-like receptor signaling pathway—TNF—rheumatoid arthritis	1.58e-05	0.000205	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—RASGRP1—rheumatoid arthritis	1.57e-05	0.000204	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—CD79A—rheumatoid arthritis	1.57e-05	0.000203	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—SYK—rheumatoid arthritis	1.57e-05	0.000203	CbGpPWpGaD
Auranofin—IKBKB—Signaling by Interleukins—IL6—rheumatoid arthritis	1.56e-05	0.000202	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—PTK2—rheumatoid arthritis	1.55e-05	0.000201	CbGpPWpGaD
Auranofin—IKBKB—B Cell Activation—NFKB1—rheumatoid arthritis	1.55e-05	0.000201	CbGpPWpGaD
Auranofin—ALB—Selenium Micronutrient Network—NFKB1—rheumatoid arthritis	1.55e-05	0.000201	CbGpPWpGaD
Auranofin—ALB—Metabolism—FADS2—rheumatoid arthritis	1.54e-05	0.0002	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—PRKCQ—rheumatoid arthritis	1.54e-05	0.000199	CbGpPWpGaD
Auranofin—IKBKB—Immune System—IRAK1—rheumatoid arthritis	1.52e-05	0.000197	CbGpPWpGaD
Auranofin—ALB—Platelet degranulation—VEGFA—rheumatoid arthritis	1.52e-05	0.000197	CbGpPWpGaD
Auranofin—ALB—Folate Metabolism—TNF—rheumatoid arthritis	1.52e-05	0.000196	CbGpPWpGaD
Auranofin—IKBKB—Activated TLR4 signalling—IL6—rheumatoid arthritis	1.5e-05	0.000195	CbGpPWpGaD
Auranofin—ALB—Vitamin B12 Metabolism—IL6—rheumatoid arthritis	1.5e-05	0.000195	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—CSF2—rheumatoid arthritis	1.5e-05	0.000194	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—TYK2—rheumatoid arthritis	1.49e-05	0.000193	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—TYK2—rheumatoid arthritis	1.46e-05	0.00019	CbGpPWpGaD
Auranofin—ALB—Hemostasis—IL2RB—rheumatoid arthritis	1.46e-05	0.000189	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—TGFB1—rheumatoid arthritis	1.45e-05	0.000189	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—VCAM1—rheumatoid arthritis	1.45e-05	0.000188	CbGpPWpGaD
Auranofin—IKBKB—Immune System—IL2RB—rheumatoid arthritis	1.45e-05	0.000188	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—HLA-DQA1—rheumatoid arthritis	1.45e-05	0.000187	CbGpPWpGaD
Auranofin—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—rheumatoid arthritis	1.44e-05	0.000187	CbGpPWpGaD
Auranofin—IKBKB—Toll Like Receptor 4 (TLR4) Cascade—IL6—rheumatoid arthritis	1.42e-05	0.000184	CbGpPWpGaD
Auranofin—ALB—Hemostasis—SELE—rheumatoid arthritis	1.41e-05	0.000183	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PDE2A—rheumatoid arthritis	1.4e-05	0.000182	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CTSK—rheumatoid arthritis	1.4e-05	0.000181	CbGpPWpGaD
Auranofin—IKBKB—Immune System—C5—rheumatoid arthritis	1.4e-05	0.000181	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—IFNG—rheumatoid arthritis	1.39e-05	0.000181	CbGpPWpGaD
Auranofin—ALB—Platelet degranulation—TGFB1—rheumatoid arthritis	1.39e-05	0.00018	CbGpPWpGaD
Auranofin—IKBKB—Immune System—MBL2—rheumatoid arthritis	1.39e-05	0.00018	CbGpPWpGaD
Auranofin—IKBKB—Immune System—NFATC1—rheumatoid arthritis	1.37e-05	0.000178	CbGpPWpGaD
Auranofin—IKBKB—Immune System—IRF5—rheumatoid arthritis	1.37e-05	0.000178	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—PTK2—rheumatoid arthritis	1.36e-05	0.000177	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—TNF—rheumatoid arthritis	1.36e-05	0.000176	CbGpPWpGaD
Auranofin—IKBKB—Immune System—REL—rheumatoid arthritis	1.35e-05	0.000175	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—HLA-DQB1—rheumatoid arthritis	1.35e-05	0.000175	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—IL2RA—rheumatoid arthritis	1.35e-05	0.000175	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PLB1—rheumatoid arthritis	1.34e-05	0.000173	CbGpPWpGaD
Auranofin—ALB—Folate Metabolism—TP53—rheumatoid arthritis	1.34e-05	0.000173	CbGpPWpGaD
Auranofin—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—rheumatoid arthritis	1.33e-05	0.000172	CbGpPWpGaD
Auranofin—ALB—Hemostasis—ITGAM—rheumatoid arthritis	1.32e-05	0.000172	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CCR6—rheumatoid arthritis	1.31e-05	0.00017	CbGpPWpGaD
Auranofin—IKBKB—Immune System—ITGAM—rheumatoid arthritis	1.31e-05	0.00017	CbGpPWpGaD
Auranofin—IKBKB—Immune System—IRF8—rheumatoid arthritis	1.31e-05	0.00017	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—ALOX5—rheumatoid arthritis	1.28e-05	0.000166	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—AGER—rheumatoid arthritis	1.28e-05	0.000166	CbGpPWpGaD
Auranofin—IKBKB—Immune System—NCF2—rheumatoid arthritis	1.28e-05	0.000166	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—CD40LG—rheumatoid arthritis	1.28e-05	0.000166	CbGpPWpGaD
Auranofin—IKBKB—Regulation of toll-like receptor signaling pathway—IL6—rheumatoid arthritis	1.27e-05	0.000165	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—HLA-B—rheumatoid arthritis	1.26e-05	0.000164	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—CD8A—rheumatoid arthritis	1.26e-05	0.000164	CbGpPWpGaD
Auranofin—IKBKB—Toll-Like Receptors Cascades—IL6—rheumatoid arthritis	1.26e-05	0.000163	CbGpPWpGaD
Auranofin—ALB—Hemostasis—SH2B3—rheumatoid arthritis	1.26e-05	0.000163	CbGpPWpGaD
Auranofin—IKBKB—Immune System—FCGR2A—rheumatoid arthritis	1.25e-05	0.000163	CbGpPWpGaD
Auranofin—IKBKB—Immune System—TRAF6—rheumatoid arthritis	1.25e-05	0.000162	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—IL1B—rheumatoid arthritis	1.24e-05	0.000161	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—IL2—rheumatoid arthritis	1.24e-05	0.000161	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—RBPJ—rheumatoid arthritis	1.23e-05	0.00016	CbGpPWpGaD
Auranofin—IKBKB—Immune System—TNFAIP3—rheumatoid arthritis	1.23e-05	0.00016	CbGpPWpGaD
Auranofin—ALB—Folate Metabolism—IL6—rheumatoid arthritis	1.22e-05	0.000159	CbGpPWpGaD
Auranofin—IKBKB—Immune System—BLK—rheumatoid arthritis	1.22e-05	0.000158	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—HLA-B—rheumatoid arthritis	1.21e-05	0.000157	CbGpPWpGaD
Auranofin—ALB—Transmembrane transport of small molecules—SLC11A1—rheumatoid arthritis	1.21e-05	0.000157	CbGpPWpGaD
Auranofin—ALB—Selenium Micronutrient Network—TNF—rheumatoid arthritis	1.2e-05	0.000156	CbGpPWpGaD
Auranofin—IKBKB—Immune System—PTPN2—rheumatoid arthritis	1.2e-05	0.000156	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—TP53—rheumatoid arthritis	1.2e-05	0.000155	CbGpPWpGaD
Auranofin—IKBKB—Immune System—SAA1—rheumatoid arthritis	1.18e-05	0.000152	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—C3—rheumatoid arthritis	1.17e-05	0.000152	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—FN1—rheumatoid arthritis	1.17e-05	0.000152	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—NFKB1—rheumatoid arthritis	1.16e-05	0.00015	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CTSD—rheumatoid arthritis	1.15e-05	0.000149	CbGpPWpGaD
Auranofin—IKBKB—Immune System—NCF1—rheumatoid arthritis	1.15e-05	0.000149	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—NFKB1—rheumatoid arthritis	1.14e-05	0.000148	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—C3—rheumatoid arthritis	1.13e-05	0.000146	CbGpPWpGaD
Auranofin—ALB—Hemostasis—GATA3—rheumatoid arthritis	1.13e-05	0.000146	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—HLA-A—rheumatoid arthritis	1.13e-05	0.000146	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—MAPK8—rheumatoid arthritis	1.12e-05	0.000145	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—CRP—rheumatoid arthritis	1.12e-05	0.000145	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CD28—rheumatoid arthritis	1.11e-05	0.000144	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CXCL13—rheumatoid arthritis	1.09e-05	0.000141	CbGpPWpGaD
Auranofin—IKBKB—Immune System—PTPRC—rheumatoid arthritis	1.09e-05	0.000141	CbGpPWpGaD
Auranofin—IKBKB—Immune System—IL1RN—rheumatoid arthritis	1.08e-05	0.00014	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—TLR4—rheumatoid arthritis	1.07e-05	0.000139	CbGpPWpGaD
Auranofin—ALB—Hemostasis—TIMP1—rheumatoid arthritis	1.07e-05	0.000138	CbGpPWpGaD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—IL6—rheumatoid arthritis	1.05e-05	0.000136	CbGpPWpGaD
Auranofin—IKBKB—Immune System—HLA-DPB1—rheumatoid arthritis	1.05e-05	0.000136	CbGpPWpGaD
Auranofin—IKBKB—Immune System—UBE2D1—rheumatoid arthritis	1.04e-05	0.000135	CbGpPWpGaD
Auranofin—ALB—Metabolism—PLD4—rheumatoid arthritis	1.03e-05	0.000133	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—HLA-DRB1—rheumatoid arthritis	1.03e-05	0.000133	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—IL6ST—rheumatoid arthritis	1.03e-05	0.000133	CbGpPWpGaD
Auranofin—IKBKB—Immune System—ADRBK1—rheumatoid arthritis	1.01e-05	0.000131	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CD40—rheumatoid arthritis	1.01e-05	0.000131	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CTLA4—rheumatoid arthritis	9.96e-06	0.000129	CbGpPWpGaD
Auranofin—IKBKB—Immune System—HMGB1—rheumatoid arthritis	9.96e-06	0.000129	CbGpPWpGaD
Auranofin—ALB—Metabolism—ACAN—rheumatoid arthritis	9.94e-06	0.000129	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—CD80—rheumatoid arthritis	9.89e-06	0.000128	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—ICAM1—rheumatoid arthritis	9.86e-06	0.000128	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—IRAK1—rheumatoid arthritis	9.82e-06	0.000127	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—TLE3—rheumatoid arthritis	9.82e-06	0.000127	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CX3CR1—rheumatoid arthritis	9.72e-06	0.000126	CbGpPWpGaD
Auranofin—ALB—Selenium Micronutrient Network—IL6—rheumatoid arthritis	9.71e-06	0.000126	CbGpPWpGaD
Auranofin—ALB—Hemostasis—RASGRP1—rheumatoid arthritis	9.6e-06	0.000125	CbGpPWpGaD
Auranofin—ALB—Hemostasis—SYK—rheumatoid arthritis	9.57e-06	0.000124	CbGpPWpGaD
Auranofin—IKBKB—Immune System—RASGRP1—rheumatoid arthritis	9.53e-06	0.000124	CbGpPWpGaD
Auranofin—IKBKB—Immune System—SYK—rheumatoid arthritis	9.5e-06	0.000123	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CD79A—rheumatoid arthritis	9.5e-06	0.000123	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—CD80—rheumatoid arthritis	9.5e-06	0.000123	CbGpPWpGaD
Auranofin—ALB—Hemostasis—PRKCQ—rheumatoid arthritis	9.4e-06	0.000122	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—IL2RB—rheumatoid arthritis	9.35e-06	0.000121	CbGpPWpGaD
Auranofin—ALB—Metabolism—SLC25A12—rheumatoid arthritis	9.35e-06	0.000121	CbGpPWpGaD
Auranofin—IKBKB—Immune System—PRKCQ—rheumatoid arthritis	9.32e-06	0.000121	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—IL6R—rheumatoid arthritis	9.17e-06	0.000119	CbGpPWpGaD
Auranofin—IKBKB—Immune System—STAT1—rheumatoid arthritis	9.16e-06	0.000119	CbGpPWpGaD
Auranofin—ALB—Metabolism—GC—rheumatoid arthritis	9.09e-06	0.000118	CbGpPWpGaD
Auranofin—ALB—Metabolism—PTGES—rheumatoid arthritis	9.09e-06	0.000118	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—C5—rheumatoid arthritis	9.03e-06	0.000117	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—NFATC1—rheumatoid arthritis	8.89e-06	0.000115	CbGpPWpGaD
Auranofin—IKBKB—Immune System—VCAM1—rheumatoid arthritis	8.79e-06	0.000114	CbGpPWpGaD
Auranofin—IKBKB—Immune System—HLA-DQA1—rheumatoid arthritis	8.77e-06	0.000114	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CCR6—rheumatoid arthritis	8.49e-06	0.00011	CbGpPWpGaD
Auranofin—ALB—Metabolism—PLB1—rheumatoid arthritis	8.45e-06	0.00011	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—TYK2—rheumatoid arthritis	8.35e-06	0.000108	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—NCF2—rheumatoid arthritis	8.26e-06	0.000107	CbGpPWpGaD
Auranofin—IKBKB—Immune System—HLA-DQB1—rheumatoid arthritis	8.2e-06	0.000106	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—SH2B3—rheumatoid arthritis	8.05e-06	0.000104	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—TRAF6—rheumatoid arthritis	8.05e-06	0.000104	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—GZMB—rheumatoid arthritis	8e-06	0.000104	CbGpPWpGaD
Auranofin—ALB—Hemostasis—PTK2—rheumatoid arthritis	7.99e-06	0.000104	CbGpPWpGaD
Auranofin—IKBKB—Immune System—PTK2—rheumatoid arthritis	7.93e-06	0.000103	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—IL2—rheumatoid arthritis	7.91e-06	0.000103	CbGpPWpGaD
Auranofin—IKBKB—Immune System—IL1A—rheumatoid arthritis	7.79e-06	0.000101	CbGpPWpGaD
Auranofin—IKBKB—Immune System—IL18—rheumatoid arthritis	7.77e-06	0.000101	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CXCL2—rheumatoid arthritis	7.77e-06	0.000101	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CCL3—rheumatoid arthritis	7.77e-06	0.000101	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CD40LG—rheumatoid arthritis	7.74e-06	0.0001	CbGpPWpGaD
Auranofin—ALB—Hemostasis—CSF2—rheumatoid arthritis	7.72e-06	0.0001	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CD8A—rheumatoid arthritis	7.66e-06	9.93e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CSF2—rheumatoid arthritis	7.66e-06	9.93e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—SAA1—rheumatoid arthritis	7.6e-06	9.85e-05	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—CD4—rheumatoid arthritis	7.55e-06	9.79e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—AGER—rheumatoid arthritis	7.47e-06	9.68e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—NCF1—rheumatoid arthritis	7.44e-06	9.65e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—MED1—rheumatoid arthritis	7.41e-06	9.61e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—HLA-B—rheumatoid arthritis	7.36e-06	9.55e-05	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—IL6—rheumatoid arthritis	7.28e-06	9.44e-05	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—CD4—rheumatoid arthritis	7.25e-06	9.4e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—IL6—rheumatoid arthritis	7.16e-06	9.28e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CD28—rheumatoid arthritis	7.15e-06	9.28e-05	CbGpPWpGaD
Auranofin—ALB—Hemostasis—IL2RA—rheumatoid arthritis	6.96e-06	9.02e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—IL2RA—rheumatoid arthritis	6.9e-06	8.95e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—B3GNT2—rheumatoid arthritis	6.89e-06	8.94e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—ACP5—rheumatoid arthritis	6.89e-06	8.94e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—C3—rheumatoid arthritis	6.84e-06	8.87e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—HLA-A—rheumatoid arthritis	6.82e-06	8.85e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—UBE2D1—rheumatoid arthritis	6.74e-06	8.74e-05	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—VEGFA—rheumatoid arthritis	6.72e-06	8.72e-05	CbGpPWpGaD
Auranofin—ALB—Hemostasis—MMP1—rheumatoid arthritis	6.64e-06	8.61e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—BDKRB2—rheumatoid arthritis	6.61e-06	8.57e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CXCL12—rheumatoid arthritis	6.61e-06	8.57e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—ADRBK1—rheumatoid arthritis	6.53e-06	8.47e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CRP—rheumatoid arthritis	6.51e-06	8.44e-05	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—NFKB1—rheumatoid arthritis	6.5e-06	8.44e-05	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—MAPK8—rheumatoid arthritis	6.39e-06	8.29e-05	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—NFKB1—rheumatoid arthritis	6.25e-06	8.1e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—TLR4—rheumatoid arthritis	6.24e-06	8.09e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—HLA-DRB1—rheumatoid arthritis	6.23e-06	8.08e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—BGN—rheumatoid arthritis	6.2e-06	8.05e-05	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—TGFB1—rheumatoid arthritis	6.17e-06	8e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—RASGRP1—rheumatoid arthritis	6.16e-06	7.99e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—SYK—rheumatoid arthritis	6.14e-06	7.96e-05	CbGpPWpGaD
Auranofin—ALB—Hemostasis—FN1—rheumatoid arthritis	6.06e-06	7.85e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PRKCQ—rheumatoid arthritis	6.03e-06	7.82e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—IL6ST—rheumatoid arthritis	5.98e-06	7.76e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—ICAM1—rheumatoid arthritis	5.98e-06	7.76e-05	CbGpPWpGaD
Auranofin—ALB—Hemostasis—NOS2—rheumatoid arthritis	5.98e-06	7.76e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—STAT1—rheumatoid arthritis	5.92e-06	7.68e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CXCL10—rheumatoid arthritis	5.84e-06	7.57e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CD80—rheumatoid arthritis	5.76e-06	7.47e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—ALOX5—rheumatoid arthritis	5.71e-06	7.41e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—IL6R—rheumatoid arthritis	5.34e-06	6.92e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—MMP3—rheumatoid arthritis	5.32e-06	6.9e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PTK2—rheumatoid arthritis	5.13e-06	6.65e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CCL5—rheumatoid arthritis	5.03e-06	6.52e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—POMC—rheumatoid arthritis	5.02e-06	6.51e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CSF2—rheumatoid arthritis	4.95e-06	6.42e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—TYK2—rheumatoid arthritis	4.86e-06	6.31e-05	CbGpPWpGaD
Auranofin—ALB—Hemostasis—NOS3—rheumatoid arthritis	4.81e-06	6.24e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—ENO1—rheumatoid arthritis	4.65e-06	6.04e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—SPP1—rheumatoid arthritis	4.65e-06	6.04e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—IFNG—rheumatoid arthritis	4.55e-06	5.9e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CCR5—rheumatoid arthritis	4.53e-06	5.87e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—IL2RA—rheumatoid arthritis	4.46e-06	5.79e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—C3—rheumatoid arthritis	4.42e-06	5.74e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CD4—rheumatoid arthritis	4.4e-06	5.7e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—LEP—rheumatoid arthritis	4.12e-06	5.34e-05	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—IL6—rheumatoid arthritis	4.08e-06	5.29e-05	CbGpPWpGaD
Auranofin—ALB—Hemostasis—IL2—rheumatoid arthritis	4.08e-06	5.29e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—IL1B—rheumatoid arthritis	4.06e-06	5.27e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—IL2—rheumatoid arthritis	4.05e-06	5.25e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—PTGS2—rheumatoid arthritis	4.01e-06	5.19e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—FN1—rheumatoid arthritis	3.88e-06	5.04e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—IL6ST—rheumatoid arthritis	3.87e-06	5.02e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—NFKB1—rheumatoid arthritis	3.79e-06	4.91e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—MAPK8—rheumatoid arthritis	3.72e-06	4.83e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CD80—rheumatoid arthritis	3.72e-06	4.83e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—POMC—rheumatoid arthritis	3.54e-06	4.59e-05	CbGpPWpGaD
Auranofin—ALB—Hemostasis—VEGFA—rheumatoid arthritis	3.47e-06	4.49e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CCL2—rheumatoid arthritis	3.46e-06	4.49e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—IL6R—rheumatoid arthritis	3.45e-06	4.48e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—CAT—rheumatoid arthritis	3.35e-06	4.35e-05	CbGpPWpGaD
Auranofin—ALB—Hemostasis—TGFB1—rheumatoid arthritis	3.18e-06	4.13e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—TYK2—rheumatoid arthritis	3.14e-06	4.08e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—NOS3—rheumatoid arthritis	3.09e-06	4e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—MTHFR—rheumatoid arthritis	2.8e-06	3.63e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CXCL8—rheumatoid arthritis	2.74e-06	3.55e-05	CbGpPWpGaD
Auranofin—ALB—Hemostasis—TP53—rheumatoid arthritis	2.62e-06	3.4e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—IL2—rheumatoid arthritis	2.62e-06	3.39e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—MMP9—rheumatoid arthritis	2.48e-06	3.21e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—NFKB1—rheumatoid arthritis	2.45e-06	3.18e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—MAPK8—rheumatoid arthritis	2.41e-06	3.12e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—IL6—rheumatoid arthritis	2.38e-06	3.08e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—POMC—rheumatoid arthritis	2.24e-06	2.9e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—VEGFA—rheumatoid arthritis	2.22e-06	2.88e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—TGFB1—rheumatoid arthritis	2.04e-06	2.65e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—NOS3—rheumatoid arthritis	1.95e-06	2.53e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—PTGS2—rheumatoid arthritis	1.78e-06	2.31e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—TP53—rheumatoid arthritis	1.68e-06	2.18e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—IL6—rheumatoid arthritis	1.54e-06	1.99e-05	CbGpPWpGaD
